Neurological
Cancer

Oncology Solutions

In the United States, about 23,820 malignant tumors of the brain or spinal cord will be diagnosed in 2019.1 With the technological advances in the technology field, brain tumor imaging has become an essential component in managing the patients across the care pathway.


The Patient Journey

  • Early Detection

    SIGNA™ Artist AIR™ Edition

    SIGNA™ Artist AIR™ Edition, GE Healthcare’s p...
  • Diagnosis

    SIGNA™ Architect AIR™ Edition

    SIGNA™ Architect AIR™ Edition, GE Healthcare’s premium 3.0T, 70 cm wide bore MR system, leverages intelligent scanning technology to enable patient-friendly exams with ...

  • Staging

    SIGNA™ Premier AIR™ Edition

    This leading and innovative 3.0T, wide bore MR system, brings you uncompromised 60 cm performance in a 70 cm bore for advanced imaging and research.

    The SIGNA™ Pre...
  • Treatment Planning

    MR Radiation Oncology Suite

    Our MR Radiation Oncology Suite provides the tools designed to help you better target and treat tumors through consistent patient positioning.
  • Therapy and Monitoring

    PET VCAR

    Comprehensive PET oncology analysis solution with multi-modality and multi-time metabolic and anatomic evolution comparison.
  • Follow up

    SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...

The latest in Oncology


1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html